Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.
The award will support the development of diagnostics and analytical tools for childhood disease detection using tissue-based fluorescent in situ sequencing.
Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
Researchers at Smith College used NGS and a Galaxy-based software called RepeatExplorer to design improved assays for soil-transmitted helminths.
Affymetrix has created a new custom genotyping array for the project, which aims to increase rice production for small farms in Africa and Asia.
The company is currently in discussions with several investor groups and plans to use the funds to expand the reach of the test and prepare for FDA submission.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
Three philanthropies have teamed up on a new program to support early career researchers in the biomedical sciences.
Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.
With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.